• Goverment of India
  • Invest India
Banner

An Overview

Stasis is an FDA-cleared remote patient monitoring system that allows clinicians to see 6 continuous vital signs (heart rate, blood oxygen, electrocardiogram, respiratory rate, blood pressure, temperature) of their patients from anywhere for continuous cardiac and respiratory monitoring.

The Objective

What pain-point does it solve?

Reduction in exposure to clinicians and nurses through remote monitoring.
Improved utilization of ICU resources for ventilated patients by expanding monitored beds.
Prevents patients from requiring ventilation through timely response to cardiac and respiratory changes.

A sneak peak at our image gallery

Browse Now
The Objective

Who are the ideal users of our technology?

Hospitals and nursing homes

The Objective

How does it solve the pain-point?

Stasis is working with hospital partners to create isolation wings. With a quick few-hour setup, Stasis reduces the patients requiring ICU resources, and by monitoring vital signs remotely the technology can save hundreds of staff hours per day while limiting medical worker exposure to COVID-19.

The Objective

What makes us stand apart from competitors ?

Plug and play technology, which can go live in <1 day and can be deployed in multiple care settings from ICU’s to private patient rooms.
Its instant cloud access to create remote command centers to empower COVID-19 task force teams. The multi-condition platform with all required vital signs measured and remotely available.

The Objective

The story of our successful deployments

Over 45 Hospitals across India use Stasis, from large corporates to government facilities. Customers include: Ramaiah Hospitals, Fortis Hospitals, Columbia Asia Hospitals, HCG Hospitals, IQRAA Hospital, and government hospitals.
Over 25,000 patients have been treated using Stasis, greatly improving outcomes and improving patient care

Get in Touch

If you have any queries, please don’t hesitate to get in touch.
We are looking forward to hearing from you.